All patients in pembrolizumab trial were found to be cancer-free after combination of drug and surgery
A “gamechanger” immunotherapy drug that “melts away” tumours dramatically increases the chances of curing bowel cancer and may even replace the need for surgery, doctors have said.
Pembrolizumab targets and blocks a specific protein on the surface of immune cells that then seek out and destroy cancer cells.
More Stories
Newborns treated with antibiotics respond less well to vaccines, study shows
As a geneticist, I will not mourn 23andMe and its jumble of useless health information | Adam Rutherford
Bonobos may combine words in ways previously thought unique to humans